Investors Are Waking Up To Predictive Oncology Inc (NASDAQ: POAI) After Losing -62.07% Over The Past 12 Months

Predictive Oncology Inc (NASDAQ:POAI) currently has a daily average trading volume of 1.83M but it saw 160713973 shares traded in last market. With a market cap of 7.67M USD, the company’s current market price of $1.87 came rising about 74.77 while comparing to the previous closing price of $1.07. In past 52 weeks, the stock remained buoying in the range of price level as high as $5.94 and as low as $0.89.

Taking a look at 20-day trading activity of Predictive Oncology Inc (POAI) gives us an average price of $1.1060, while its current price level is -68.52% below from 52-week high level whereas it is 109.17% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $1.3014 while that of 200 days or SMA-200 reads an average of $2.4277. A closer look into the stock’s movement over the week reveals that its volatility is standing at 22.82% during that period while stretching the period over a month that decreases to 10.27%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 75.47 which implies that the stock is in overbought territory.

Over the week, POAI’s stock price is moving 59.83% up while it is 76.42% when we observe its performance for the past one month. Year-to-date it is -43.16% down and over the past year, the stock is showing a downside performance of -62.07%.

The latest quarterly earnings report issued by the company reported quarterly earnings per share (EPS) of -0.05 beat the consensus estimate of -0.07 for the same. Moreover, analysts are in estimates of $372k for current-quarter revenue.

Currently, Predictive Oncology Inc’s total number of outstanding shares is 4.06M. Company’s return on investment (ROI) stands at -243.07% and return on equity (ROE) at -130.76%. Stock’s beta reads 1.14. Stock has a price to book (P/B) ratio of 1.87 while price to sale or P/S ratio amounts to 3.91. Its return on asset (ROA) is -82.89% on average.